Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing

Optimum, cost-effective, and pragmatic screening for and diagnosis of important health disorders remains a key aspect of clinical care. With this in mind, the American Diabetes Association formally accepted the use of HbA1c as a diagnostic test for type 2 diabetes in January, 2010.1 Although this de...